Virus-inhibiting activity in the cerebro-spinal fluid from patients with acute and chronic neurological diseases.
D000208:Acute Disease; D000818:Animals; D000998:Antiviral Agents / Q000134:cerebrospinal fluid*; D002908:Chronic Disease; D046508:Culture Techniques; D004660:Encephalitis / Q000134:cerebrospinal fluid; D004890:Erythema; D005347:Fibroblasts; D006358:Hot Temperature; D006801:Humans; D007372:Interferons; D008581:Meningitis / Q000134:cerebrospinal fluid; D051379:Mice; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid*; D009437:Neuralgia / Q000134:cerebrospinal fluid; D009443:Neuritis / Q000134:cerebrospinal fluid; D012672:Semliki forest virus; D014357:Trypsin; D014461:Ultracentrifugation
D000998:Antiviral Agents; D007372:Interferons; D014357:Trypsin